Reported number of people receiving antiretroviral therapy in Zambia
Zambia: Reported number of people receiving antiretroviral therapy was 1.24 million in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Zambia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Zambia recorded 1.24 million for reported number of people receiving antiretroviral therapy in 2025.
The figure is down 0.1% on the previous year and up 64.0% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Zambia peaked at 1.25 million in 2023 and was at its lowest, 0, in 2000.
That places Zambia 7th out of 143 countries with data for 2025, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Zambia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 142 | — |
| 2003 | 15,328 | +10694.4% |
| 2004 | 29,998 | +95.7% |
| 2005 | 57,165 | +90.6% |
| 2006 | 85,882 | +50.2% |
| 2007 | 163,843 | +90.8% |
| 2008 | 227,977 | +39.1% |
| 2009 | 285,767 | +25.3% |
| 2010 | 349,076 | +22.2% |
| 2011 | 423,721 | +21.4% |
| 2012 | 479,881 | +13.3% |
| 2013 | 559,764 | +16.6% |
| 2014 | 653,701 | +16.8% |
| 2015 | 758,646 | +16.1% |
| 2016 | 798,723 | +5.3% |
| 2017 | 833,938 | +4.4% |
| 2018 | 943,289 | +13.1% |
| 2019 | 1.05 million | +11.1% |
| 2020 | 1.16 million | +10.4% |
| 2021 | 1.17 million | +1.6% |
| 2022 | 1.25 million | +6.0% |
| 2023 | 1.25 million | +0.2% |
| 2024 | 1.25 million | -0.2% |
| 2025 | 1.24 million | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86,610 | 0 | 285,767 | 10 |
| 2010s | 684,834 | 349,076 | 1.05 million | 10 |
| 2020s | 1.22 million | 1.16 million | 1.25 million | 6 |
Countries ranked near Zambia
More health data for Zambia
- Un projection of annual infant deaths, annual growth rate -1.09 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 809.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,894 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 1.68 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0743 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.69 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Zambia?
- Reported number of people receiving antiretroviral therapy in Zambia was 1.24 million in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Zambia?
- The highest recorded value was 1.25 million in 2023.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Zambia?
- The lowest recorded value was 0 in 2000.
- How does Zambia rank for reported number of people receiving antiretroviral therapy?
- Zambia ranks 7th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Zambia?
- Over the last ten years it is up 64.0%. The long-run trend across the full record is volatile.
- Where does this Zambia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).